Bronchopulmonary dysplasia

[1]  G. Nijpels,et al.  Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study , 2021, Diabetologia.

[2]  Safety Study , 2020, Definitions.

[3]  J. Giri,et al.  Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2019, Journal of the American Heart Association.

[4]  J. Pillow,et al.  Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis. , 2019, Paediatric respiratory reviews.

[5]  B. Poindexter,et al.  The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach , 2019, American journal of respiratory and critical care medicine.

[6]  J. Pillow,et al.  Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia. , 2019, American journal of respiratory and critical care medicine.

[7]  J. Silvestri,et al.  Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants. , 2019, The Journal of pediatrics.

[8]  D. Brousseau,et al.  Parent Preferences Regarding Home Oxygen Use for Infants with Bronchopulmonary Dysplasia. , 2019, The Journal of pediatrics.

[9]  R. Ohls,et al.  Oxygen Disrupts Human Fetal Lung Mesenchymal Cells. Implications for Bronchopulmonary Dysplasia , 2019, American journal of respiratory cell and molecular biology.

[10]  B. Poindexter,et al.  Early Pulmonary Vascular Disease in Preterm Infants Is Associated with Late Respiratory Outcomes in Childhood , 2019, American journal of respiratory and critical care medicine.

[11]  K. Watterberg,et al.  Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. , 2019, The Journal of pediatrics.

[12]  A. Avila-Alvarez,et al.  Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia , 2019, PloS one.

[13]  E. Morrisey,et al.  Early lineage specification defines alveolar epithelial ontogeny in the murine lung , 2019, Proceedings of the National Academy of Sciences.

[14]  A. Lewandowski,et al.  Preterm Birth Is a Novel, Independent Risk Factor for Altered Cardiac Remodeling and Early Heart Failure: Is it Time for a New Cardiomyopathy? , 2019, Current Treatment Options in Cardiovascular Medicine.

[15]  Deborah Discenza,et al.  Remembering the Power of Stories in Pediatric Research. , 2019, The Journal of pediatrics.

[16]  W. Göpel,et al.  Genetics of bronchopulmonary dysplasia: When things do not match up, it is only the beginning. , 2019, The Journal of pediatrics.

[17]  V. Bhandari,et al.  Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics , 2019, Metabolomics.

[18]  F. Cools,et al.  Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial , 2019, JAMA.

[19]  Samriddha Ray,et al.  Single cell RNA analysis identifies cellular heterogeneity and adaptive responses of the lung at birth , 2019, Nature Communications.

[20]  Y. Chang,et al.  Neonatal Outcomes of Very Low Birth Weight Infants in Korean Neonatal Network from 2013 to 2016 , 2019, Journal of Korean medical science.

[21]  J. Whitsett,et al.  Building and Regenerating the Lung Cell by Cell. , 2019, Physiological reviews.

[22]  E. Kuhn,et al.  Assessment of quality of life in pediatric patients with pulmonary hypertension , 2018, Pulmonary circulation.

[23]  L. Kalish,et al.  Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.

[24]  Lois E. H. Smith,et al.  rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial , 2018, The Journal of pediatrics.

[25]  Sean B Fain,et al.  Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short‐Term Clinical Outcomes , 2018, American journal of respiratory and critical care medicine.

[26]  S. DeMauro,et al.  Living with Severe Bronchopulmonary Dysplasia-Parental Views of Their Child's Quality of Life. , 2018, The Journal of pediatrics.

[27]  G. Melen,et al.  Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile. , 2018, Cytotherapy.

[28]  A. Gaggar,et al.  Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[29]  R. Savani.  Modulators of inflammation in Bronchopulmonary Dysplasia. , 2018, Seminars in perinatology.

[30]  R. Keller,et al.  Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia. , 2018, Seminars in perinatology.

[31]  L. Doyle,et al.  An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. , 2018, Seminars in perinatology.

[32]  V. Fainardi,et al.  Lung function in a cohort of 5‐year‐old children born very preterm , 2018, Pediatric pulmonology.

[33]  S. Bhattacharya,et al.  Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth , 2018, BMC Genetics.

[34]  B. Thébaud,et al.  Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia. , 2018, Seminars in perinatology.

[35]  N. Ambalavanan,et al.  Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia , 2018, Seminars in perinatology.

[36]  R. Morty.  Recent advances in the pathogenesis of BPD. , 2018, Seminars in perinatology.

[37]  J. Pillow,et al.  Increased prevalence of expiratory flow limitation during exercise in children with bronchopulmonary dysplasia , 2018, ERJ Open Research.

[38]  S. Kotecha,et al.  Persistent and progressive long-term lung disease in survivors of preterm birth. , 2018, Paediatric respiratory reviews.

[39]  C. Ito,et al.  Impaired Angiogenic Supportive Capacity and Altered Gene Expression Profile of Resident CD146+ Mesenchymal Stromal Cells Isolated from Hyperoxia-Injured Neonatal Rat Lungs. , 2018, Stem cells and development.

[40]  A. Malhotra,et al.  First‐In‐Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study , 2018, Stem Cells Translational Medicine.

[41]  H. Burris,et al.  Moving beyond race and ethnicity to understand the effect of inhaled nitric oxide on bronchopulmonary dysplasia prevention. , 2018, The Journal of pediatrics.

[42]  R. Wood‐Baker,et al.  Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. , 2018, The Lancet. Respiratory medicine.

[43]  A. Jobe,et al.  Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. , 2018, American journal of obstetrics and gynecology.

[44]  W. Oh,et al.  Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.

[45]  M. Palta,et al.  Early Pulmonary Vascular Disease in Young Adults Born Preterm , 2018, American journal of respiratory and critical care medicine.

[46]  L. Doyle,et al.  Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration , 2018, JAMA.

[47]  A. Hamvas,et al.  Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age , 2018, The Journal of pediatrics.

[48]  J. Pillow,et al.  Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study. , 2018, The Lancet. Child & adolescent health.

[49]  S. McGrath-Morrow,et al.  Respiratory Phenotypes for Preterm Infants, Children, and Adults: Bronchopulmonary Dysplasia and More , 2018, Annals of the American Thoracic Society.

[50]  M. Puhan,et al.  Variability of Very Low Birth Weight Infant Outcome and Practice in Swiss and US Neonatal Units , 2018, Pediatrics.

[51]  T. Raju,et al.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop , 2018, The Journal of pediatrics.

[52]  P. Dey,et al.  Bronchopulmonary Dysplasia in Preterm Neonates in a Level III Neonatal Unit in India , 2018, Indian Pediatrics.

[53]  S. Steele,et al.  Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers , 2018, Pediatric pulmonology.

[54]  E. Burchard,et al.  Ancestry and Genetic Associations with Bronchopulmonary Dysplasia in Preterm Infants , 2018, bioRxiv.

[55]  E. Morrisey,et al.  Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor , 2018, Nature.

[56]  C. Meisner,et al.  Long‐Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia , 2018, The New England journal of medicine.

[57]  G. Hall,et al.  The impact of respiratory viruses on lung health after preterm birth , 2018, European clinical respiratory journal.

[58]  V. Fellman,et al.  Lung function after extremely preterm birth—A population‐based cohort study (EXPRESS) , 2018, Pediatric pulmonology.

[59]  N. Marlow,et al.  Pulmonary Artery Pressures in School‐Age Children Born Prematurely , 2017, The Journal of pediatrics.

[60]  F. Harrell,et al.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension , 2017, JAMA cardiology.

[61]  W. Göpel,et al.  Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development , 2017, The Journal of pediatrics.

[62]  R. Morty,et al.  Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[63]  N. Finer,et al.  Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial , 2017, The Journal of pediatrics.

[64]  H. Olschewski,et al.  Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality , 2017, American journal of respiratory and critical care medicine.

[65]  B. Thébaud,et al.  Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells , 2017, Chest.

[66]  L. Doyle,et al.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.

[67]  D. Moher,et al.  Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies , 2017, Stem cells translational medicine.

[68]  P. McNamara,et al.  Preview : Published ahead of advance online publication Controversies in the identification and management of acute pulmonary hypertension in preterm neonates , 2017 .

[69]  C. McEvoy,et al.  Can We Prevent Bronchopulmonary Dysplasia? , 2017, The Journal of pediatrics.

[70]  Jonathan E. Elliott,et al.  Exaggerated Increase in Pulmonary Artery Pressure during Exercise in Adults Born Preterm. , 2017, American journal of respiratory and critical care medicine.

[71]  W. Carlo,et al.  Using Quality Improvement Tools to Reduce Chronic Lung Disease. , 2017, Clinics in perinatology.

[72]  C. Delacourt,et al.  Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene , 2017, Scientific Reports.

[73]  B. Poindexter,et al.  Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants , 2017, American journal of respiratory and critical care medicine.

[74]  P. Shaw,et al.  Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. , 2017, The Journal of pediatrics.

[75]  R. Brant,et al.  A Time‐Based Analysis of Inflammation in Infants at Risk of Bronchopulmonary Dysplasia , 2018, The Journal of pediatrics.

[76]  A. Jobe,et al.  Can We Define Bronchopulmonary Dysplasia? , 2017, The Journal of pediatrics.

[77]  N. Gotteiner,et al.  Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia‐Associated Pulmonary Hypertension , 2017, The Journal of pediatrics.

[78]  M. Nishihara,et al.  Longitudinal impairment of lung function in school‐age children with extremely low birth weights , 2017, Pediatric pulmonology.

[79]  D. Tibboel,et al.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment , 2017, Front. Med..

[80]  D. Mohamed,et al.  Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age , 2017, JAMA.

[81]  L. Palermo,et al.  The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1‐Year Corrected Age , 2017, The Journal of pediatrics.

[82]  S. Abman,et al.  Fetal Vascular Origins of Bronchopulmonary Dysplasia. , 2017, The Journal of pediatrics.

[83]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[84]  Paolo Marchionni,et al.  New Insights on Early Patterns of Respiratory Disease among Extremely Low Gestational Age Newborns , 2017, Neonatology.

[85]  Jeffrey S. Buzas,et al.  Variation in Performance of Neonatal Intensive Care Units in the United States , 2017, JAMA pediatrics.

[86]  Shoo K. Lee,et al.  Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates , 2017, JAMA pediatrics.

[87]  J. Feinstein,et al.  Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.

[88]  E. Bancalari,et al.  The Evolution of Bronchopulmonary Dysplasia after 50 Years. , 2017, American journal of respiratory and critical care medicine.

[89]  R. A. Sinkin,et al.  Evidence of Early Pulmonary Hypertension Is Associated with Increased Mortality in Very Low Birth Weight Infants , 2017, American Journal of Perinatology.

[90]  B. Vohr,et al.  Survival and Neurodevelopmental Outcomes among Periviable Infants , 2017, The New England journal of medicine.

[91]  M. Keszler,et al.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia , 2017, The Journal of pediatrics.

[92]  B. Maron,et al.  Translational Advances in the Field of Pulmonary Hypertension., Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension , 2017, American journal of respiratory and critical care medicine.

[93]  A. V. van Kaam,et al.  Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.

[94]  J. Pillow,et al.  Altered lung structure and function in mid-childhood survivors of very preterm birth , 2017, Thorax.

[95]  L. Gortner,et al.  Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study , 2017, PloS one.

[96]  A. Regev,et al.  Scaling single-cell genomics from phenomenology to mechanism , 2017, Nature.

[97]  G. Kadmon,et al.  Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia , 2017, Pediatric pulmonology.

[98]  P. Davis,et al.  Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. , 2016, The Cochrane database of systematic reviews.

[99]  M. Kumar,et al.  Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis , 2016, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[100]  W. Callaghan,et al.  Effects of Maternal Age and Age-Specific Preterm Birth Rates on Overall Preterm Birth Rates - United States, 2007 and 2014. , 2016, MMWR. Morbidity and mortality weekly report.

[101]  H. Zar,et al.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis , 2016, Pediatric pulmonology.

[102]  D. Black,et al.  Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. , 2016, The Journal of pediatrics.

[103]  R. Mori,et al.  Neonatal Outcomes of Very Low Birth Weight and Very Preterm Neonates: An International Comparison. , 2016, The Journal of pediatrics.

[104]  Praveen K. Chandrasekharan,et al.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach? , 2016, American Journal of Perinatology.

[105]  L. García-Marcos,et al.  Lung function gain in preterm infants with and without bronchopulmonary dysplasia , 2016, Pediatric pulmonology.

[106]  B. Darlow,et al.  Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants. , 2016, The Cochrane database of systematic reviews.

[107]  W. Carlo,et al.  The Airway Microbiome at Birth , 2016, Scientific Reports.

[108]  S. Abman,et al.  Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia , 2016, American Journal of Perinatology.

[109]  D. Nicholas,et al.  Altered breathing mechanics and ventilatory response during exercise in children born extremely preterm , 2016, Thorax.

[110]  G. Shaw,et al.  The genetic predisposition to bronchopulmonary dysplasia , 2016, Current opinion in pediatrics.

[111]  J. Aschner,et al.  Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate , 2016, Journal of Perinatology.

[112]  D. Mohamed,et al.  Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial , 2016, The Lancet.

[113]  S. Abman,et al.  A Standardized Discharge Process Decreases Length of Stay for Ventilator-Dependent Children , 2016, Pediatrics.

[114]  Peter W Zandstra,et al.  Quality cell therapy manufacturing by design , 2016, Nature Biotechnology.

[115]  R. Green.  Early inhaled budesonide for the prevention of bronchopulmonary dysplasia , 2016 .

[116]  G. Grunwald,et al.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2016, Circulation.

[117]  B. Resch,et al.  Prematurity and the burden of influenza and respiratory syncytial virus disease , 2016, World Journal of Pediatrics.

[118]  K. Albertine,et al.  Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials. , 2016, Current clinical pharmacology.

[119]  V. Bhandari,et al.  Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia , 2015, Front. Med..

[120]  B. Poindexter,et al.  Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. , 2015, Annals of the American Thoracic Society.

[121]  N. Ambalavanan,et al.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.

[122]  P. Mourani,et al.  Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia. , 2015, Clinics in perinatology.

[123]  S. Kallapur,et al.  Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. , 2015, Clinics in perinatology.

[124]  G. Eide,et al.  Respiratory illness contributed significantly to morbidity in children born extremely premature or with extremely low birthweights in 1999–2000 , 2015, Acta paediatrica.

[125]  M. Hallman,et al.  New BPD predicts lung function at school age: Follow‐up study and meta‐analysis , 2015, Pediatric pulmonology.

[126]  Jian-Guo Zhou,et al.  Mortality and Morbidity of Extremely Low Birth Weight Infants in the Mainland of China: A Multi-center Study , 2015, Chinese medical journal.

[127]  C. Meisner,et al.  Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. , 2015, The New England journal of medicine.

[128]  R. Romero,et al.  Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. , 2015, American journal of obstetrics and gynecology.

[129]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[130]  J. Gould,et al.  Determinants of chronic lung disease severity in the first year of life; A population based study , 2015, Pediatric pulmonology.

[131]  A. V. van Kaam,et al.  Accuracy of the Diagnosis of Bronchopulmonary Dysplasia in a Referral-Based Health Care System. , 2015, The Journal of pediatrics.

[132]  A. Jobe.  Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease , 2015, Front. Med..

[133]  W. Göpel,et al.  Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. , 2015, JAMA pediatrics.

[134]  M. Oka,et al.  Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial , 2015, Cancer Immunology, Immunotherapy.

[135]  M. Rämet,et al.  Genes Encoding Vascular Endothelial Growth Factor A (VEGF-A) and VEGF Receptor 2 (VEGFR-2) and Risk for Bronchopulmonary Dysplasia , 2015, Neonatology.

[136]  J. Collaco,et al.  Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia , 2015, American Journal of Perinatology.

[137]  B. Haglund,et al.  Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia , 2015, Acta paediatrica.

[138]  W. Hsieh,et al.  Neonatal outcomes of extremely preterm infants from taiwan: comparison with Canada, Japan, and the USA. , 2015, Pediatrics and neonatology.

[139]  G. Shaw,et al.  Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort. , 2015, JAMA pediatrics.

[140]  J. Whitsett,et al.  Diseases of pulmonary surfactant homeostasis. , 2015, Annual review of pathology.

[141]  J. Whitsett,et al.  Respiratory epithelial cells orchestrate pulmonary innate immunity , 2014, Nature Immunology.

[142]  L. Doyle,et al.  An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.

[143]  J. Aschner,et al.  L‐citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants , 2014, Acta paediatrica.

[144]  J. Carlin,et al.  The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation , 2014, BMC Pediatrics.

[145]  Elizabeth A. Calle,et al.  Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. , 2014, Cell stem cell.

[146]  N. Gotteiner,et al.  Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. , 2014, Placenta.

[147]  E. Eichenwald,et al.  Inhaled Nitric Oxide Increases Urinary Nitric Oxide Metabolites and Cyclic Guanosine Monophosphate in Premature Infants: Relationship to Pulmonary Outcome , 2014, American Journal of Perinatology.

[148]  A. Fraser,et al.  Cardiovascular function in children who had chronic lung disease of prematurity , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[149]  Hye Soo Yoo,et al.  Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. , 2014, The Journal of pediatrics.

[150]  B. Schmidt,et al.  Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. , 2014, Annals of the American Thoracic Society.

[151]  N. Neff,et al.  Reconstructing lineage hierarchies of the distal lung epithelium using single cell RNA-seq , 2014, Nature.

[152]  L. Ernst,et al.  Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study. , 2014, Early human development.

[153]  C. Lal,et al.  Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II). , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[154]  M. Kemp,et al.  Repeated exposure to intra-amniotic LPS partially protects against adverse effects of intravenous LPS in preterm lambs , 2014, Innate immunity.

[155]  D. DeMaso,et al.  Quality of life and parental adjustment in pediatric pulmonary hypertension. , 2014, Chest.

[156]  Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis , 2014, BMJ : British Medical Journal.

[157]  A. Jobe,et al.  Fetal Immune Response to Chorioamnionitis , 2014, Seminars in Reproductive Medicine.

[158]  L. Papile,et al.  Respiratory Support in Preterm Infants at Birth , 2014, Pediatrics.

[159]  N. Marlow,et al.  Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study , 2013, BMC Pediatrics.

[160]  R. Dweik,et al.  Clinical Characterization and Survival of Patients with Borderline Elevation in Pulmonary Artery Pressure , 2013, Pulmonary circulation.

[161]  Yun Cao,et al.  Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide , 2013, PloS one.

[162]  M. Kumar,et al.  Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis , 2013, BMJ.

[163]  B. Thébaud,et al.  Stem cell-based therapy for neonatal lung disease—it’s in the juice , 2013, Pediatric Research.

[164]  O. Koroglu,et al.  Cardiovascular Consequences of Bronchopulmonary Dysplasia in Prematurely Born Preschool Children , 2013, Neonatology.

[165]  V. Bhandari,et al.  Biomarkers in bronchopulmonary dysplasia. , 2013, Paediatric respiratory reviews.

[166]  J. Aschner,et al.  Looking beyond PPHN: The Unmet Challenge of Chronic Progressive Pulmonary Hypertension in the Newborn , 2013, Pulmonary circulation.

[167]  J. Francis,et al.  Right Ventricular Systolic Dysfunction in Young Adults Born Preterm , 2013, Circulation.

[168]  G. Badger,et al.  Obstetric and Neonatal Care Practices for Infants 501 to 1500 g From 2000 to 2009 , 2013, Pediatrics.

[169]  M Gissler,et al.  Preterm birth time trends in Europe: a study of 19 countries , 2013, BJOG : an international journal of obstetrics and gynaecology.

[170]  C. Kuehni,et al.  Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance. , 2013, American journal of respiratory and critical care medicine.

[171]  F. Dunstan,et al.  Effect of preterm birth on later FEV1: a systematic review and meta-analysis , 2013, Thorax.

[172]  E. Williams,et al.  Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. , 2013, The Journal of pediatrics.

[173]  N. Gotteiner,et al.  Fetal Growth Restriction and Pulmonary Hypertension in Premature Infants with Bronchopulmonary Dysplasia , 2012, Journal of Perinatology.

[174]  Pablo Lamata,et al.  Preterm Heart in Adult Life: Cardiovascular Magnetic Resonance Reveals Distinct Differences in Left Ventricular Mass, Geometry, and Function , 2012, Circulation.

[175]  A. Jefferies.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2012, Paediatrics & child health.

[176]  M. Hallman,et al.  Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. , 2012, The Journal of pediatrics.

[177]  A. Jobe.  Effects of chorioamnionitis on the fetal lung. , 2012, Clinics in perinatology.

[178]  E. Svensen,et al.  Prophylactic versus Selective Use of Surfactant in Preventing Morbidity and Mortality in Preterm Infants , 2012, Neonatology.

[179]  G. Buonocore,et al.  Oxidative Stress and Bronchopulmonary Dysplasia , 2012, Journal of clinical neonatology.

[180]  J. Carlin,et al.  Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure , 2012, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[181]  H. Halliday,et al.  General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. , 2012, Chest.

[182]  P. Mourani,et al.  Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia , 2012, European Respiratory Journal.

[183]  W. Carlo,et al.  Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.

[184]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[185]  Marius Mada,et al.  Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. , 2012, American journal of respiratory and critical care medicine.

[186]  F. Polack,et al.  Human Rhinoviruses in Severe Respiratory Disease in Very Low Birth Weight Infants , 2012, Pediatrics.

[187]  C. Delacourt,et al.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. , 2011, American journal of respiratory and critical care medicine.

[188]  Ahmed A. Mahfouz,et al.  Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. , 2011, Journal of tropical pediatrics.

[189]  R. Ehrenkranz,et al.  Inhaled Nitric Oxide in Preterm Infants: An Individual-Patient Data Meta-analysis of Randomized Trials , 2011, Pediatrics.

[190]  R. Ehrenkranz,et al.  Patterns of Blood Protein Concentrations of ELGANs Classified by Three Patterns of Respiratory Disease in the First 2 Postnatal Weeks , 2011, Pediatric Research.

[191]  M. Kemp,et al.  Chronic Fetal Exposure to Ureaplasma parvum Suppresses Innate Immune Responses in Sheep , 2011, The Journal of Immunology.

[192]  L. Hartling,et al.  Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[193]  M. Walsh,et al.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. , 2011, American journal of respiratory and critical care medicine.

[194]  A. Jobe.  The new bronchopulmonary dysplasia , 2011, Current opinion in pediatrics.

[195]  J. Davis,et al.  Future applications of antioxidants in premature infants , 2011, Current opinion in pediatrics.

[196]  N. Finer,et al.  An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[197]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[198]  R. Ehrenkranz,et al.  Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[199]  G. Kim,et al.  Review article DOI: 10.3345/kjp.2010.53.6.688 , 2010 .

[200]  Zhangsheng Yu,et al.  Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. , 2010, American journal of respiratory and critical care medicine.

[201]  J. Folkman,et al.  Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. , 2010, The Journal of pediatrics.

[202]  E. Bae,et al.  Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.

[203]  S. Archer,et al.  Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. , 2009, American journal of respiratory and critical care medicine.

[204]  O. Liang,et al.  Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. , 2009, American journal of respiratory and critical care medicine.

[205]  R. Ehrenkranz,et al.  Fetal Growth Restriction and Chronic Lung Disease Among Infants Born Before the 28th Week of Gestation , 2009, Pediatrics.

[206]  R. Soll,et al.  Animal derived surfactant extract for treatment of respiratory distress syndrome. , 2009, The Cochrane database of systematic reviews.

[207]  W. Carlo,et al.  Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants , 2009, Pediatrics.

[208]  R. Ehrenkranz,et al.  Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants , 2009, Pediatrics.

[209]  E. Kajantie,et al.  Endostatin Concentration in Cord Plasma Predicts the Development of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants , 2009, Pediatrics.

[210]  N. Sugino,et al.  MMP‐9 and TIMP‐1 in the cord blood of premature infants developing BPD , 2009, Pediatric pulmonology.

[211]  A. Milner,et al.  Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.

[212]  K. Jang,et al.  Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health , 2008, Pediatrics.

[213]  Q. Mao,et al.  Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. , 2008, American journal of respiratory and critical care medicine.

[214]  Ophir D. Klein,et al.  The branching programme of mouse lung development , 2008, Nature.

[215]  W. Poole,et al.  Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure , 2008, Journal of Perinatology.

[216]  A. Gow,et al.  Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants , 2008, Pediatrics.

[217]  P. Donohue,et al.  The epidemiology of atypical chronic lung disease in extremely low birth weight infants , 2008, Journal of Perinatology.

[218]  Roberto Romero,et al.  Epidemiology and causes of preterm birth , 2008, The Lancet.

[219]  V. Bhandari,et al.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia , 2008, Biomarker insights.

[220]  S. Porzio,et al.  Epithelial Lining Fluid Neutrophil-Gelatinase-Associated Lipocalin Levels in Premature Newborns with Bronchopulmonary Dysplasia and Patency of Ductus Arteriosus , 2008, International journal of immunopathology and pharmacology.

[221]  D. McElhinney,et al.  Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.

[222]  Arne Ohlsson,et al.  Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.

[223]  J. Pillow,et al.  Bubble continuous positive airway pressure enhances lung volume and gas exchange in preterm lambs. , 2007, American journal of respiratory and critical care medicine.

[224]  A. Cipriani,et al.  What is an individual patient data meta-analysis? , 2007, Epidemiologia e Psichiatria Sociale.

[225]  S. Nanua,et al.  Lung cells from neonates show a mesenchymal stem cell phenotype. , 2007, American journal of respiratory and critical care medicine.

[226]  B. Thébaud,et al.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. , 2007, American journal of respiratory and critical care medicine.

[227]  R. Savani,et al.  Inflammatory Markers and Mediators in Tracheal Fluid of Premature Infants Treated With Inhaled Nitric Oxide , 2007, Pediatrics.

[228]  J. Carlin,et al.  Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasonef , 2007, Pediatrics.

[229]  R. Polin,et al.  The Contribution of Intermittent Hypoxemia to Late Neurological Handicap in Mice with Hyperoxia-Induced Lung Injury , 2007, Neonatology.

[230]  T. Ogihara,et al.  Plasma KL-6 Predicts the Development and Outcome of Bronchopulmonary Dysplasia , 2006, Pediatric Research.

[231]  J. Hauth,et al.  The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. , 2006, American journal of obstetrics and gynecology.

[232]  L. Doyle,et al.  Neurodevelopmental outcome of bronchopulmonary dysplasia. , 2006, Seminars in perinatology.

[233]  L. Doyle,et al.  Caffeine therapy for apnea of prematurity. , 2006, The New England journal of medicine.

[234]  C. Romagnoli,et al.  Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia , 2006, Intensive Care Medicine.

[235]  J. Carlin,et al.  Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial , 2006, Pediatrics.

[236]  B. Poindexter,et al.  Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. , 2005, The Journal of pediatrics.

[237]  M. Walsh,et al.  Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.

[238]  L. Wright,et al.  Prolonged Hospital Stay for Extremely Premature Infants: Risk Factors, Center Differences, and the Impact of Mortality on Selecting a Best-Performing Center , 2005, Journal of Perinatology.

[239]  D. Carlton,et al.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. , 2005, American journal of respiratory and critical care medicine.

[240]  O. Saugstad.  Oxidative Stress in the Newborn – A 30-Year Perspective , 2005, Neonatology.

[241]  June-Dong Park,et al.  Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[242]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[243]  J. Choi,et al.  Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[244]  W. Truog,et al.  Dysfunction of Pulmonary Surfactant in Chronically Ventilated Premature Infants , 2004, Pediatric Research.

[245]  K. Watterberg,et al.  Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter Trial , 2004, Pediatrics.

[246]  M. Walsh,et al.  Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates , 2004, Pediatrics.

[247]  J. Whitsett,et al.  Genetic disorders influencing lung formation and function at birth. , 2004, Human molecular genetics.

[248]  James E. Morrow.  The University of Washington , 2004 .

[249]  G. Escobar,et al.  Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. , 2004, The Journal of pediatrics.

[250]  F. Hsieh,et al.  Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. , 2004, Pediatrics.

[251]  H. Scholefield,et al.  Atypical chronic lung disease in preterm infants , 2004, Journal of perinatal medicine.

[252]  B. Vohr,et al.  Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? , 2003, American journal of obstetrics and gynecology.

[253]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[254]  S. Abman.  Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.

[255]  W. Poole,et al.  Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 2001, The New England journal of medicine.

[256]  W. Truog,et al.  Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. , 2000, Pediatrics.

[257]  P. Chambon,et al.  Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. , 2000, Physiological genomics.

[258]  B. Yoder,et al.  High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. , 2000, American journal of respiratory and critical care medicine.

[259]  R. Bland,et al.  Chronic Lung Disease in Early Infancy , 2000 .

[260]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[261]  H. Lagercrantz,et al.  Early motor and mental development in very preterm infants with chronic lung disease , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[262]  N. Finer,et al.  Postnatal steroids: short-term gain, long-term pain? , 2000, The Journal of pediatrics.

[263]  W. Carlo,et al.  Long-Term Follow-up of Premature Infants Treated With Prophylactic, Intratracheal Recombinant Human CuZn Superoxide Dismutase , 2000, Journal of Perinatology.

[264]  M. Moore,et al.  Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. , 2000, Pediatrics.

[265]  J. Hauth,et al.  Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.

[266]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[267]  P. Ballard.  Scientific rationale for the use of antenatal glucocorticoids to promote fetal development. , 2000, Pediatrics in review.

[268]  M. Rämet,et al.  Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. , 2000, American journal of human genetics.

[269]  D. Massaro,et al.  Retinoic acid treatment partially rescues failed septation in rats and in mice. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[270]  D. Warburton,et al.  Bioactive Transforming Growth Factor-Beta in the Lungs of Extremely Low Birthweight Neonates Predicts the Need for Home Oxygen Supplementation , 2000, Neonatology.

[271]  J. Flynn,et al.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. , 2000, Pediatrics.

[272]  T. Bunch,et al.  Circulating neutrophil concentration and respiratory distress in premature infants. , 2000, The Journal of pediatrics.

[273]  M. G,et al.  Randomized trial of Permissive hypercapnia in preterm infants , 2000 .

[274]  K. Watterberg,et al.  Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. , 2000, Pediatrics.

[275]  K. Watterberg,et al.  Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. , 1999, Pediatrics.

[276]  J. Kennedy.  Lung function outcome in children of premature birth , 1999, Journal of paediatrics and child health.

[277]  A. Jobe.  The New BPD: An Arrest of Lung Development , 1999, Pediatric Research.

[278]  M. Frid,et al.  Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[279]  T. O'Shea,et al.  Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants , 1999 .

[280]  K. Blyth,et al.  Role of Ureaplasma urealyticum in lung disease of prematurity , 1999, Archives of disease in childhood. Fetal and neonatal edition.

[281]  B. Yoder,et al.  Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.

[282]  E. Bancalari,et al.  CLINICAL COURSE AND LUNG FUNCTION ABNORMALITIES DURING DEVELOPMENT OF NEONATAL CHRONIC LUNG DISEASE , 1999 .

[283]  S. Saigal.  Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. , 1999, The Journal of pediatrics.

[284]  C. Bose,et al.  Population-based Study of Chronic Lung Disease in Very Low Birth Weight Infants in North Carolina in 1994 With Comparisons With 1984 , 1999, Pediatrics.

[285]  J. Whitsett,et al.  Molecular mechanisms controlling lung morphogenesis , 1999, Clinical genetics.

[286]  J. Tyson,et al.  VITAMIN A SUPPLEMENTATION FOR EXTREMELY-LOW-BIRTH-WEIGHT INFANTS , 1999 .

[287]  P. Minoo,et al.  Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. , 1999, Developmental biology.

[288]  D. Phelps,et al.  Atypical Chronic Lung Disease Patterns in Neonates , 1999, Pediatrics.

[289]  A. Salvator,et al.  Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. , 1999, JAMA.

[290]  J. Rosenbloom,et al.  TGF-beta1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung. , 1998, The American journal of physiology.

[291]  R. Soll.  Synthetic surfactant for respiratory distress syndrome in preterm infants. , 1998, The Cochrane database of systematic reviews.

[292]  A. Husain,et al.  Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. , 1998, Human pathology.

[293]  J. Wispé,et al.  Functional and pathological effects of prolonged hyperoxia in neonatal mice. , 1998, American Journal of Physiology.

[294]  O. Saugstad,et al.  Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD? , 1997, Acta paediatrica.

[295]  A. Jobe,et al.  Glucocorticoid regulation of surfactant components in immature lambs. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[296]  D. Carlton,et al.  Role of neutrophils in lung vascular injury and edema after premature birth in lambs. , 1997, Journal of applied physiology.

[297]  D. Massaro,et al.  Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats , 1997, Nature Medicine.

[298]  R. Pierce,et al.  Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.

[299]  S. Ryan,et al.  Prediction of chronic neonatal lung disease on day 4 of life , 1996, European Journal of Pediatrics.

[300]  R. Parker,et al.  Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. , 1996, Seminars in perinatology.

[301]  K. Watterberg,et al.  Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.

[302]  J. Coalson,et al.  Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. , 1995, American journal of respiratory and critical care medicine.

[303]  R. Romero,et al.  Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. , 1995, American journal of obstetrics and gynecology.

[304]  P. Groneck,et al.  Inflammatory mediators and bronchopulmonary dysplasia. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[305]  E. Bancalari,et al.  Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. , 1995, The Journal of pediatrics.

[306]  K. Watterberg,et al.  Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. , 1995, Pediatrics.

[307]  R. Levine,et al.  Oxidation of proteins in neonatal lungs. , 1994, Pediatrics.

[308]  E. Bancalari,et al.  Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. , 1993, The Journal of pediatrics.

[309]  T. T. Rhodes,et al.  Financial and Emotional Cost Of Bronchopulmonary Dysplasia , 1993, Clinical pediatrics.

[310]  J. Davis,et al.  Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. , 1993, Journal of applied physiology.

[311]  K. Hoppu,et al.  Inositol supplementation in premature infants with respiratory distress syndrome. , 1992, The New England journal of medicine.

[312]  S. Innis,et al.  Intralipid Increases Lung Polyunsaturated Fatty Acids and Protects Newborn Rats from Oxygen Toxicity , 1991, Pediatric Research.

[313]  R. Popp,et al.  Late pulmonary sequelae of bronchopulmonary dysplasia. , 1990, The New England journal of medicine.

[314]  A. Ohlsson,et al.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. , 1988, Pediatrics.

[315]  E. Bancalari,et al.  Serial determination of pulmonary function in infants with chronic lung disease. , 1987, The Journal of pediatrics.

[316]  W. Morgan,et al.  Expiratory flow limitation in infants with bronchopulmonary dysplasia. , 1986, The Journal of pediatrics.

[317]  A. Hart.  The University of Utah , 1986 .

[318]  R. Mellins,et al.  Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. , 1985, The American review of respiratory disease.

[319]  J. Fouron,et al.  Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. , 1980, Pediatrics.

[320]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[321]  J. Versalovic,et al.  Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review , 2019, The Journal of pediatrics.

[322]  A. Agustí,et al.  Early Life Origins of Asthma: A Review of Potential Effectors. , 2019, Journal of investigational allergology & clinical immunology.

[323]  L. Askie,et al.  Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta‐Analysis , 2018, The Journal of pediatrics.

[324]  M. Ericsson,et al.  Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.

[325]  L. Doyle,et al.  Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.

[326]  C. McEvoy,et al.  Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. , 2017, Paediatric respiratory reviews.

[327]  C. Day,et al.  Bronchopulmonary dysplasia: new becomes old again! , 2017, Pediatric Research.

[328]  Sharon L. Wright,et al.  Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. , 2016, The Journal of pediatrics.

[329]  T. Yeh,et al.  Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. , 2016, American journal of respiratory and critical care medicine.

[330]  B. Poindexter,et al.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.

[331]  H. Uhlig,et al.  Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. , 2014, The Journal of pediatrics.

[332]  P. Davis,et al.  Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. , 2014, The Cochrane database of systematic reviews.

[333]  J. Baron,et al.  Institute of Child Health and Human Development, National Institutes of Health, Bethesda, , 2014 .

[334]  Zhiqun Zhang,et al.  Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review , 2013, European Journal of Pediatrics.

[335]  Yahya Al Ethawi.  Elective High-Frequency Oscillatory Ventilation Versus Conventional Ventilation for Acute Pulmonary Dysfunction in Preterm Infants , 2012, Journal of clinical neonatology.

[336]  L. Nelin,et al.  Chapter 21 – Management of the Infant with Severe Bronchopulmonary Dysplasia , 2012 .

[337]  C. O’Donnell,et al.  High flow nasal cannula for respiratory support in preterm infants. , 2011, The Cochrane database of systematic reviews.

[338]  F. Roelfsema,et al.  multi-center study. , 2011 .

[339]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[340]  W. Carlo,et al.  The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. , 2008, American journal of obstetrics and gynecology.

[341]  L. Papile.  Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasone , 2008 .

[342]  K. Barrington,et al.  Inhaled nitric oxide for respiratory failure in preterm infants. , 2001, The Cochrane database of systematic reviews.

[343]  P. Burri,et al.  Development and growth of the lung , 2007 .

[344]  J. Morrow,et al.  Inhaled Nitric Oxide Attenuates Hyperoxic Lung Injury in Lambs , 2006, Pediatric Research.

[345]  K. Stenmark,et al.  Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. , 2005, Annual review of physiology.

[346]  L. Monte,et al.  [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.

[347]  R. Fry,et al.  COVID-19 Infection Risk amongst 14,104 Vaccinated Care Home Residents: A national observational longitudinal cohort study in Wales, United Kingdom, December 2020 to March 2021 , 2021, medRxiv.

[348]  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. , 2002, Paediatrics & child health.

[349]  H. Halliday.  Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. , 2001, The Journal of pediatrics.

[350]  C R Bauer,et al.  Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. , 2001, Pediatrics.

[351]  Bart Nooteboom,et al.  An International Comparison , 2000 .

[352]  M. Palta,et al.  Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Newborn Lung Project. , 2000, Archives of pediatrics & adolescent medicine.

[353]  S. Abman.  PULMONARY HYPERTENSION IN CHRONIC LUNG DISEASE OF INFANCY : PATHOGENESIS, PATHOPHYSIOLOGY, AND TREATMENT , 2000 .

[354]  K. Stenmark,et al.  Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes. , 2000, American journal of respiratory cell and molecular biology.

[355]  C. Bose,et al.  Population-based study of chronic lung disease in very low birth weight infants in North Carolina in 1994 with comparisons with 1984. The North Carolina Neonatologists Association. , 1999, Pediatrics.

[356]  T. O'Shea,et al.  Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. , 1999, Pediatrics.

[357]  J. Tyson,et al.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. , 1998, American journal of obstetrics and gynecology.

[358]  D. Cox,et al.  alpha1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. , 1998, Pediatrics.

[359]  A. Slutsky,et al.  VENTILATOR-INDUCED LUNG INJURY : MECHANISMS AND CLINICAL CORRELATES , 1998 .

[360]  M. Palta,et al.  Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. , 1998, The Journal of pediatrics.

[361]  P. Burri,et al.  Postnatal lung development and its impairment by glucocorticoids. , 1997, Pediatric pulmonology. Supplement.

[362]  E. Baraldi,et al.  Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. , 1997, American journal of respiratory and critical care medicine.

[363]  J. Zimmerman,et al.  Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. , 1996, Critical care medicine.

[364]  D. Massaro,et al.  Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. , 1996, Annual review of physiology.

[365]  P. Burri,et al.  Influence of postnatally administered glucocorticoids on rat lung growth. , 1995, Biology of the neonate.

[366]  E. Bancalari,et al.  Bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[367]  Joshua Lederberg,et al.  Children's Hospital of Philadelphia. , 1975, The Australasian nurses journal.

[368]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[369]  THE JUICE , 2022 .